Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Spinal muscular atrophy: A comprehensive case report

Breadcrumb

  • Home
  • Spinal muscular atrophy: A comprehensive case report

VARSHINI MALLAMPATI *

Department of Pharmacy Practice, Chalapathi institute of pharmaceutical sciences, Guntur, Andhra Pradesh, India.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 18(01), 196–197.
Article DOI: 10.30574/wjbphs.2024.18.1.0188
DOI url: https://doi.org/10.30574/wjbphs.2024.18.1.0188

Received on 28 February 2024; revised on 08 April 2024; accepted on 11 April 2024

Muscle Weakness and Atrophy, Hypotonia, Progressive Degeneration, Motor Function Impairment are hallmarks of Spinal Muscular Atrophy, a neuromuscular genetically inherited disorder that causes muscle weakness and wasting usually diagnosed in infancy or early childhood and rarely identified in adults. The genetic components of the disease are inherited, meaning that the afflicted individual receives the gene from a parent with the same genetic makeup. It is inherited in an autosomal-recessive manner. The survival motor neuron gene 1 (SMN1) is the gene responsible for the most prevalent kind of SMA. A patient with Spinal Muscular Atrophy is described, associated their clinical with and genetic features.

Spinal Muscular Atrophy (SMA); Supportive therapy; Survival motor neuron (SMN); Muscle Weakness; Atrophy; Progressive Degeneration

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0188.pdf

Preview Article PDF

VARSHINI MALLAMPATI. Spinal muscular atrophy: A comprehensive case report. World Journal of Biology Pharmacy and Health Sciences, 2024, 18(01), 196–197. Article DOI: https://doi.org/10.30574/wjbphs.2024.18.1.0188

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution